CN1248597C - Forest frog oil soft capsule - Google Patents
Forest frog oil soft capsule Download PDFInfo
- Publication number
- CN1248597C CN1248597C CNB011388641A CN01138864A CN1248597C CN 1248597 C CN1248597 C CN 1248597C CN B011388641 A CNB011388641 A CN B011388641A CN 01138864 A CN01138864 A CN 01138864A CN 1248597 C CN1248597 C CN 1248597C
- Authority
- CN
- China
- Prior art keywords
- frog oil
- soft capsule
- oil
- forest frog
- wood frog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 9
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- 235000008524 evening primrose extract Nutrition 0.000 claims abstract description 6
- 229940089020 evening primrose oil Drugs 0.000 claims abstract description 6
- 239000010475 evening primrose oil Substances 0.000 claims abstract description 6
- 241000191896 Rana sylvatica Species 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- -1 hydroxyl hydrogen Chemical compound 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 241000269436 Ranidae Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Abstract
The present invention relates to a forest frog oil soft capsule which is scientifically prepared from various natural substances, such as evening primrose oil, forest frog oil, vitamin E, tea polyphenol, etc., and the product has the functions of high nutritive value, aging delay, blood fat adjustment and health care.
Description
Technical field
The present invention relates to a kind of nutrient and healthcare products, particularly relate to the Wood frog oil soft capsule of wood frog oil and evening primrose wet goods mixed preparing.
Background technology
Wood frog is commonly called as oviductus ranae, be one at aspects such as medical value, nutritive value, social value and ecological benefits, the amphibian animal ranid that all has important economic implications,------OVIDUCTUS RANAE is the famous and precious dietotherapy Chinese medicine of a kind of famous China and foreign countries of Northeast China special product to its dry fallopian tubal, is called " soft gold " by reputation on the international market.Traditional Chinese medicine and pharmacy thinks that wood frog oil has: enriching yin is mended, kidney, and qi-restoratives decreases.Be used for soreness and weakness of waist and knees, dysphoria in chestpalms-soles due to the kidney-yin deficiency, after being ill, postpartum is weak etc.Yet the said goods people are directly edible or take with dry wood frog oil vacuole water, have that mouthfeel is poor, unrighted acid wherein is easily oxidized, easily become sour, and simultaneously, it is inconvenient to store.
Summary of the invention
The objective of the invention is to overcome above-mentioned weak point, provide a kind of prescription reasonable, easily processing, it is good to take mouthfeel, is convenient to the Wood frog oil soft capsule prescription of absorption of human body.
In order to achieve the above object, the technical scheme of wood invention employing is:
Evening primrose oil 40%～80%
Wood frog oil 10%～40%
Vitamin E 5%～10%
Tea Polyphenols 5%～10%.
The specific embodiment
Below the embodiment of the invention is explained in detail:
Example 1:
Evening primrose oil 40g
Wood frog oil 40g
Vitamin E 10g
Tea Polyphenols 10g.
Example 2:
Evening primrose oil 80g
Wood frog oil 10g
Vitamin E 5g
Tea Polyphenols 5g.
Example 3:
Evening primrose oil 50g
Wood frog oil 30g
Vitamin E 10g
Tea Polyphenols 10g.
Contain a large amount of unrighted acids in the Wood frog oil soft capsule primary raw material wood frog oil serum total cholesterol, triglyceride concentration are descended, HDL raises; Effectively regulate blood fat, improve blood viscosity, reduce thrombus, recover vessel wall elasticity.Estradiol, progesterone and steroids be with human body in the identical natural hormone of steroids that produces, can regulate internal system, enhance metabolism, improve immunity of organisms, for the middle aged and aged women before and after the menopause, play a big part at aspects such as regulating internal system, anti-ageing, strong physique: and its most outstanding be that amino acid more than contained 50% above protein and 40% can make muscle more solid, elimination because of protein deficient cause wan and sallow, strengthen the elasticity of skin, promote growing of body, nutrition apace, moist cell.Thereby performance is tired, senile-resistant efficacy.The very low reducing agent of natural oil antioxidant-Tea Polyphenols one class oxidation-reduction potential of institute's adapted has active hydroxyl hydrogen in this product, and excessive combined with radical in hydrogen proton and the body can be provided, and is showing special function aspect the elimination activity oxygen radical.Experimental result proof Tea Polyphenols has the obvious suppression effect to the DNA chain fracture of hydrogen peroxide-induced, shows that Tea Polyphenols has the effect of anti-DNA oxidative damage; Outside inferior, play very big effect at the adjusting lipid aspects, can obviously reduce serum cholesterol on the one hand, LDL content and raise HDL contents, and TC, LDL there is tangible dose-effect relationship: promote lipoid substance from ight soil, to discharge on the other hand, can prevent and treat the effect that atherosclerotic has fat-reducing again.But cooperate also humidification with vitamin C and vitamin E.
Another composition vitamin E in the Wood frog oil soft capsule can reduce the existence of free radical and increasing of peroxyester matter, can prevent that brain cell is aging, promotes brain cell activity, the generation of delaying senility property disease and development.As everyone knows, the people can secondaryly give birth to " active oxygen " when utilizing oxygen, becomes oxygen poison one free radical, the infringement organism.Free radical can impel fatty over oxidation, cell membrane and cell interior structure are damaged, be known many person in middle and old age's diseases, as the inducement of ischemic, artery sclerosis, ephritis, hepatosis, cancer, diabetes, cataract, rheumatism and various inflammation etc.Vitamin E has very strong oxidation resistance, can stop cellular oxidation damage, delaying human body cell chromosome fission process, keep cell function complete, prolong cell survival, delaying human body caducity.Can also eliminate the aged pigment lipofuscin in the tissue, reduce cholesterolemia concentration, suppress arteriosclerotic effect, also have the protective hair tubule, improve microcirculation and skin elasticity, prevention cataract etc.
In sum, Wood frog oil soft capsule proportioning science, the effect uniqueness, each component again can wild phase ear curative effect in the synergistic while, be regulate blood fat, best product delays senility.
Claims (1)
1, a kind of Wood frog oil soft capsule is characterized in that this soft capsule made by following raw materials by weight percent:
Evening primrose oil 40%-80%
Wood frog oil 10%～40%
Vitamin E 5%～10%
Tea Polyphenols 5%～10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1426790A CN1426790A (en) | 2003-07-02 |
| CN1248597C true CN1248597C (en) | 2006-04-05 |
Family
ID=4674816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011388641A Expired - Fee Related CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1248597C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100415215C (en) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | Wild camellia seed oil soft capsule |
| CN101120951B (en) * | 2006-08-10 | 2010-05-12 | 孙欣 | Ovarian moisturing soft capsule and preparing process thereof |
| CN103005460A (en) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | Anti-aging rana japonica oil food |
| CN102948663A (en) * | 2012-12-19 | 2013-03-06 | 刘书新 | Rana japonica oil granules and preparation method thereof |
| CN105596424A (en) * | 2016-02-04 | 2016-05-25 | 张菊明 | Rana temporaria chensinensis and mulberry capsule for relieving stress, balancing and nourishing and preparation method thereof |
-
2001
- 2001-12-21 CN CNB011388641A patent/CN1248597C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1426790A (en) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bartram | Bartram's encyclopedia of herbal medicine | |
| Burlando et al. | Honey in dermatology and skin care: a review | |
| JP7069490B2 (en) | Yuricoma longifolia extract and its use in enhancing and / or stimulating the immune system | |
| JP4542300B2 (en) | Hyaluronic acid accumulation promoter | |
| KR102033089B1 (en) | Compositions for decreasing sebum, skin desquamation and skin suppression | |
| ES2340510T3 (en) | USE OF RENTAL-FURANS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE EXCEESS OF WEIGHT. | |
| WO2007004229A2 (en) | Methods of using pomegranate fractions for skin repair | |
| WO2007016050A1 (en) | Composition and method for treating cellulite | |
| CN105816848A (en) | Protective cream capable of dispelling dampness and preparation method thereof | |
| CN101791285B (en) | Clausenamide composite nanometer emulsion for clearing facial age pigment (lipofuscin) and preparation method thereof | |
| CN1248597C (en) | Forest frog oil soft capsule | |
| WO2013072852A1 (en) | Stretch mark preventer | |
| RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
| CN102008083B (en) | Health food for alleviating physical fatigue and removing chloasma | |
| Yagil | Cosmeceuticals: Camel and Other Milk–Natural Skin Maintenance | |
| KR20160025808A (en) | Composition having effects of preventing or recovering fatigue or stress | |
| CN103932941A (en) | Nutritional element aging resistant skin-care lotion | |
| CN106937923A (en) | Lucid ganoderma-pollen skin care health care frost | |
| KR20050067837A (en) | Composition for slimming | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
| CN102919853A (en) | Rana japonica oil soft capsule | |
| RU2442597C1 (en) | Method for obtaining extract of unripe walnuts, used in medicine, cosmectics and as food (biologically active additives) | |
| WO2020078051A1 (en) | Skin care agent containing 4-terpineol and preparation method therefor | |
| CN102948663A (en) | Rana japonica oil granules and preparation method thereof | |
| JP6712273B2 (en) | Composition for draining lymph for obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Free format text: FORMER OWNER: HARBIN JIANKANGREN SCIENCE AND SCIENCE CO. LTD. Effective date: 20050513 |
|
| C10 | Entry into substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20050513 Address after: No. 36, water source road, Miyun Industrial Development Zone, Beijing Applicant after: Beijing Yishoutang Healthcare Technology Co. Ltd. Address before: 150090 No. 20, Harbin hi tech Development Zone, Nangang District, Heilongjiang, Hengshan Road Applicant before: Harbin Jiankangren Science and Science Co. Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HARBIN RED SUN HEALTH INDUSTRY GROUP CO., LTD. Free format text: FORMER OWNER: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Effective date: 20090612 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090612 Address after: Zip code at Bohai road and Weihai Road, Harbin, China: 150069 Co-patentee after: Yishoutang Health Technology Industry Co. Ltd. Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: No. 36, water source road, Miyun Industrial Development Zone, Beijing, China: 101500 Patentee before: Beijing Yishoutang Healthcare Technology Co. Ltd. |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Termination of Patent Right |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YISHOU HALL HEALTH SCIENCE AND TECHNOLOGY INDUSTRY CO., LTD. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20110126 Address after: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Co-patentee before: Yishoutang Health Technology Industry Co. Ltd. Patentee before: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoguang Document name: Notification to Pay the Fees |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060405 Termination date: 20171221 |